efectos secundarios de la inyeccion semaglutide Las inyecciones para bajar de peso: los y precauciones a considerar Efectos secundarios de los ar-

BMI uses a persons height and weight to estimate their body fat level and gauge their risk of body fat-related diseases

During the 16-week dose escalation period, patients were titrated to WEGOVY 2.4 mg injected subcutaneously once weekly or placebo

Aetnas typical PA requirements for Wegovy and Zepbound include: Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea) Evidence of participation in a structured weight management program (diet, exercise, behavioral counseling) for a minimum period often 3 to 6 months Documentation that other weight loss interventions have been attempted Prescriber must be a physician, NP, or PA with appropriate prescribing authority Prior authorization is not a denial it is a documentation requirement

Of these, 58% were CV deaths, and 42% were non-CV deaths